Maynard Um
-
-
-
-
-
-
-
Cognition Therapeutics, Inc. (CGTX) Tops Q1 EPS by 2c
-
-
-
-
-
-
-
Cognition Therapeutics establishes $75 million stock offering program
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Cognition Therapeutics (CGTX)
-
-
-
-
-
-
-
Cognition Therapeutics, Inc. (CGTX) Reports Topline Results Showing Oral CT1812 Reduced Lesion Growth in Phase 2 Study in Geographic Atrophy
-
-
-
-
-
-
-
Cognition Therapeutics (CGTX) Publishes Research Supporting the Potential of Zervimesine in Dry AMD
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Cognition Therapeutics (CGTX)
-
-
-
-
-
-
-
Cognition Therapeutics, Inc. (CGTX) Halted, News Pending
-
444,074 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

